NXS.AX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 09:10):

Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia...

Stats
Dzisiejszy wolumen	201 976
Średni wolumen	138 035
Kapitalizacja rynkowa	99.18M
EPS	$0 ( 2024-02-27 )
Następna data zysków	( $0 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.09
ATR14	$0.00100 (0.31%)

Wolumen Korelacja

Długi: -0.14 (neutral)

Krótki: -0.85 (strong negative)

Signal:(32.082) Neutral

Next Science Ltd Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Next Science Ltd Korelacja - Waluta/Towar

0.32
( neutral )

0.22
( neutral )

0.00
( neutral )

0.21
( neutral )

Next Science Ltd Finanse

Annual	2023
Przychody:	$33.41M
Zysk brutto:	$22.78M (68.18 %)
EPS:	$-0.100

FY	2023
Przychody:	$33.41M
Zysk brutto:	$22.78M (68.18 %)
EPS:	$-0.100

FY	2022
Przychody:	$16.90M
Zysk brutto:	$11.90M (70.46 %)
EPS:	$-0.0869

FY	2021
Przychody:	$8.95M
Zysk brutto:	$6.94M (77.56 %)
EPS:	$-0.0475

Financial Reports:

No articles found.

Next Science Ltd

Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site infections. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia.